Jeanne Holden-Wiltse
Jeanne Holden-Wiltse
University of Rochester Medical Center
確認したメール アドレス: urmc.rochester.edu
タイトル
引用先
引用先
Food preferences in human obesity: carbohydrates versus fats
A Drewnowski, C Kurth, J Holden-Wiltse, J Saari
Appetite 18 (3), 207-221, 1992
3661992
Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial
JJ Treanor, GM Schiff, FG Hayden, RC Brady, CM Hay, AL Meyer, ...
Jama 297 (14), 1577-1582, 2007
1992007
Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus
H Miao, JA Hollenbaugh, MS Zand, J Holden-Wiltse, TR Mosmann, ...
Journal of virology 84 (13), 6687-6698, 2010
1912010
Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults: AIDS Clinical Trials Group Protocols 150 and 258
RM Gulick, V McAuliffe, J Holden-Wiltse, C Crumpacker, L Liebes, ...
Annals of internal medicine 130 (6), 510-514, 1999
1911999
Simulation and prediction of the adaptive immune response to influenza A virus infection
HY Lee, DJ Topham, SY Park, J Hollenbaugh, J Treanor, TR Mosmann, ...
Journal of virology 83 (14), 7151-7165, 2009
1702009
Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team.
BJ Dezube, JH Von Roenn, J Holden-Wiltse, TW Cheung, SC Remick, ...
Journal of clinical oncology 16 (4), 1444-1449, 1998
1531998
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine …
LM Demeter, RW Shafer, PM Meehan, J Holden-Wiltse, MA Fischl, ...
Antimicrobial agents and chemotherapy 44 (3), 794-797, 2000
1102000
Influenza virus vaccination elicits poorly adapted B cell responses in elderly individuals
C Henry, NY Zheng, M Huang, A Cabanov, KT Rojas, K Kaur, SF Andrews, ...
Cell host & microbe 25 (3), 357-366. e6, 2019
812019
High-resolution temporal response patterns to influenza vaccine reveal a distinct human plasma cell gene signature
AD Henn, S Wu, X Qiu, M Ruda, M Stover, H Yang, Z Liu, SL Welle, ...
Scientific reports 3 (1), 1-12, 2013
692013
Taste responses and food preferences in obese women: effects of weight cycling
A Drewnowski, J Holden-Wiltse
International journal of obesity and related metabolic disorders: journal of …, 1992
691992
Impact of prematurity and nutrition on the developing gut microbiome and preterm infant growth
A Grier, X Qiu, S Bandyopadhyay, J Holden-Wiltse, HA Kessler, AL Gill, ...
Microbiome 5 (1), 1-19, 2017
592017
Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS
JM Jacobson, R Hafner, J Remington, C Farthing, J Holden-Wiltse, ...
Aids 15 (5), 583-589, 2001
592001
A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease
AJ Japour, JJ Lertora, PM Meehan, A Erice, JD Connor, BP Griffith, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 13 (3), 235-246, 1996
571996
Modeling of influenza-specific CD8+ T cells during the primary response indicates that the spleen is a major source of effectors
H Wu, A Kumar, H Miao, J Holden-Wiltse, TR Mosmann, AM Livingstone, ...
The Journal of Immunology 187 (9), 4474-4482, 2011
452011
Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151
MA Fischl, DD Richman, C Flexner, MF Para, R Haubrich, A Karim, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 15 (1), 28-34, 1997
421997
Neonatal gut and respiratory microbiota: coordinated development through time and space
A Grier, A McDavid, B Wang, X Qiu, J Java, S Bandyopadhyay, H Yang, ...
Microbiome 6 (1), 1-19, 2018
372018
Transcriptomic biomarkers to discriminate bacterial from nonbacterial infection in adults hospitalized with respiratory illness
S Bhattacharya, AF Rosenberg, DR Peterson, K Grzesik, AM Baran, ...
Scientific reports 7 (1), 1-12, 2017
362017
ACTG 260: a randomized, phase I-II, dose-ranging trial of the anti-human immunodeficiency virus activity of delavirdine monotherapy
MF Para, P Meehan, J Holden-Wiltse, M Fischl, G Morse, R Shafer, ...
Antimicrobial agents and chemotherapy 43 (6), 1373-1378, 1999
341999
Dissociation, cellular isolation, and initial molecular characterization of neonatal and pediatric human lung tissues
G Bandyopadhyay, HL Huyck, RS Misra, S Bhattacharya, Q Wang, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 315 (4 …, 2018
262018
Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine‐mediated immune protection
ML DeDiego, CS Anderson, H Yang, J Holden‐Wiltse, T Fitzgerald, ...
Immunology 148 (2), 160-173, 2016
262016
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20